Anavex's European Dream for Blarcamesine Hits a Regulatory Wall
The Long Road to Hope: Anavex's Alzheimer's Drug Hits a Regulatory Wall
European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases